FDA Drug recall D-0144-2017
AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01)
- FDA Drug
- Class III
- terminated
- Published 2016-11-30
On 2016-11-30 the FDA classified a Class III recall of AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01) by Amerisource Health Services, citing presence of Foreign Tablets/Capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0144-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-10-13 |
| Published | 2016-11-30 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Amerisource Health Services |
| Distribution | n/a |
Product
AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx Only, Manufactured by: Actavis Elizabeth, LLC, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217
Reason
Presence of Foreign Tablets/Capsules
Identifiers
| code_info | Lot #155404 ; Exp 01/18 Lot #161139,163060,164054, 164809; Exp 03/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0144-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.